摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2,4-二氯-5-甲氧基苯胺基)-6-甲氧基-7-[(1-甲基哌啶-2-基)甲氧基]喹啉-3-腈 | 622369-26-0

中文名称
4-(2,4-二氯-5-甲氧基苯胺基)-6-甲氧基-7-[(1-甲基哌啶-2-基)甲氧基]喹啉-3-腈
中文别名
——
英文名称
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[(1-methylpiperidine-2-yl)methoxy]quinoline-3-carbonitrile
英文别名
4-(2,4-Dichloro-5-methoxyanilino)-6-methoxy-7-[(1-methylpiperidin-2-yl)methoxy]quinoline-3-carbonitrile
4-(2,4-二氯-5-甲氧基苯胺基)-6-甲氧基-7-[(1-甲基哌啶-2-基)甲氧基]喹啉-3-腈化学式
CAS
622369-26-0
化学式
C25H26Cl2N4O3
mdl
——
分子量
501.412
InChiKey
QSBWHISTPSABIV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    603.6±55.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    34
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    79.6
  • 氢给体数:
    1
  • 氢受体数:
    7

SDS

SDS:455f82f2832cb9b3d15d2d69a37ae7ce
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Process for the preparation of 7-substituted-3 quinolinecarbonitriles
    申请人:Wyeth Holdings Corporation
    公开号:US20030212276A1
    公开(公告)日:2003-11-13
    There is provided a process for the preparation of 7-substituted-3-quinolinecarbonitriles and intermediates useful in a process to prepare 7-substituted-3-quinolinecarbonitriles and pharmaceutically acceptable salts is described. Where 7-fluoro-4-oxo-1,4-dihydro-3-quinolinecarbonitrile is converted in three steps to 7-substituted-3-quinolinecarbonitriles which inhibit the action of certain protein kinases and are useful in the treatment of cancer.
    提供了一种制备7-取代-3-喹啉羰基腈和中间体的方法,该中间体在制备7-取代-3-喹啉羰基腈和药用可接受盐的过程中有用。将7-氟-4-氧代-1,4-二氢-3-喹啉羰基腈转化为7-取代-3-喹啉羰基腈,经过三个步骤,这些化合物抑制某些蛋白激酶的作用,并在癌症治疗中有用。
  • [EN] PROCESS FOR THE PREPARATION OF 7-SUBSTITUTED-3-QUINOLINE AND 3-QUINOL-4-ONE CARBONITRILES<br/>[FR] PREPARATION DE 3-QUINOLINE ET DE 3-QUINOL- 4-ONE CARBONITRILES SUBSTITUES EN POSITION 7
    申请人:WYETH CORP
    公开号:WO2003093241A1
    公开(公告)日:2003-11-13
    There is provided a process for the preparation of 7-substituted-3-quinolinecarbonitriles and intermediates useful in a process to prepare 7-substituted-3-quinolinecarbonitriles and pharmaceutically acceptable salts is described. Where 7-fluoro-4-oxo-1,4-dihydro-3-quinolinecarbonitrile is converted in three steps to 7-substituted-3-quinolinecarbonitriles which inhibit the action of certain protein kinases and are useful in the treatment of cancer.
    提供了一种制备7-取代-3-喹啉羰基腈及其中间体的方法,该中间体可用于制备7-取代-3-喹啉羰基腈及其药用可接受盐的方法。其中,7-氟-4-氧代-1,4-二氢-3-喹啉羰基腈经过三步转化成为抑制某些蛋白激酶作用且用于治疗癌症的7-取代-3-喹啉羰基腈。
  • PROCESS FOR THE PREPARATION OF 7-SUBSTITUTED-3-QUINOLINE AND 3-QUINOL-4-ONE CARBONITRILES
    申请人:Wyeth Holdings Corporation
    公开号:EP1499594A1
    公开(公告)日:2005-01-26
  • US6780996B2
    申请人:——
    公开号:US6780996B2
    公开(公告)日:2004-08-24
  • 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases
    作者:Diane H. Boschelli、Yanong D. Wang、Steve Johnson、Biqi Wu、Fei Ye、Ana Carolina Barrios Sosa、Jennifer M. Golas、Frank Boschelli
    DOI:10.1021/jm0499458
    日期:2004.3.1
    We previously reported that several 7-alkoxy-4-phenylamino-3-quinolinecarbonitriles were potent inhibitors of Src kinase activity. We disclose here a new highly efficient and versatile route to these compounds, which are also potent inhibitors of Abl kinase.
查看更多